CHRISTOPHER R. BURROW, M.D.; W. GORDON WALKER, M.D.; W. R. BELL, M.D.; OLGA B. GATEWOOD, M.D.
There is little published information on the use of fibrinolytic therapy in renal vein thrombosis. Isolated case reports (1, 2) of patients with renal vein thrombosis so treated have been unpromising but fail to constitute an adequate trial of this therapeutic approach. There are, however, several reported cases that show that heparin administered soon after thrombosis of the renal veins may be instrumental in restoring renal function jeopardized by the thrombotic occlusion (3-5). Although the potential role of fibrinolytic therapy in the treatment of renal vein thrombosis is not known, its comparative advantage over heparin in promoting rapid thrombolysis of
BURROW CR, WALKER WG, BELL WR, GATEWOOD OB. Streptokinase Salvage of Renal Function After Renal Vein Thrombosis. Ann Intern Med. ;100:237–238. doi: 10.7326/0003-4819-100-2-237
Download citation file:
Published: Ann Intern Med. 1984;100(2):237-238.
Cardiology, Hospital Medicine, Nephrology, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use